Showing results (21-30 of 134) with videos related to
Sort By:
Pageof 14
European Journal of Endocrinology|April 19, 2011
Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patientsAnouk Scholten, Menno R Vriens, Geert Jan E Cromheecke, et al.Nederlands Tijdschrift Voor Geneeskunde|February 16, 2012
[Lithium-induced hyperparathyroidism]Bernard M Houweling, Bas A Twigt, Eline J Regeer, et al.Frontiers of Hormone Research|August 26, 2015
Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary CarcinoidsKoen M A Dreijerink, Jules L Derks, Ivana Cataldo, et al.Endocrine Reviews|November 29, 2020
Multiple Endocrine Neoplasia Type 1: Latest InsightsMaria Luisa Brandi, Sunita K Agarwal, Nancy D Perrier, et al.Endocrine Connections|August 11, 2022
NETest: serial liquid biopsies in gastroenteropancreatic NET surveillanceMark J C van Treijen, Catharina M Korse, Wieke H Verbeek, et al.Clinical Nuclear Medicine|April 13, 2013
High failure rates after (131)I therapy in Graves hyperthyroidism patients with large thyroid volumes, high iodine uptake, and high iodine turnoverJeroen A F de Jong, Helena M Verkooijen, Gerlof D Valk, et al.Journal of the Endocrine Society|January 21, 2022
Is There a Role for Biomarkers in Surveillance of Pancreatic Neuroendocrine Neoplasms in Von Hippel-Lindau Disease?Myrthe R Naber, Saya Ahmad, Annemarie A Verrijn Stuart, et al.Journal of the Endocrine Society|September 12, 2018
Diagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence BaseMark J C van Treijen, Dirk-Jan van Beek, Rachel S van Leeuwaarde, et al.Endocrine Oncology (Bristol, England)|August 14, 2025
Survival and prognostic differences between appendiceal NETs and goblet cell adenocarcinomasKim Dijke, José van den Berg, Koert F D Kuhlmann, et al.Endocrine-Related Cancer|August 4, 2017
The future: medical advances in MEN1 therapeutic approaches and management strategiesRachel S van Leeuwaarde, Joanne M de Laat, Carolina R C Pieterman, et al.Pageof 14